These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3597990)

  • 1. Electrophysiologic effects of d-sotalol in humans.
    McComb JM; McGovern B; McGowan JB; Ruskin JN; Garan H
    J Am Coll Cardiol; 1987 Jul; 10(1):211-7. PubMed ID: 3597990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects of sotalol on the immature mammalian heart.
    Houyel L; Fournier A; Ducharme G; Chartrand C; Davignon A
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):134-9. PubMed ID: 1375680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics.
    Kato R; Ikeda N; Yabek SM; Kannan R; Singh BN
    J Am Coll Cardiol; 1986 Jan; 7(1):116-25. PubMed ID: 3941198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of d-sotalol and l-sotalol on the atrioventricular node of the rabbit heart.
    Beyer T; Brachmann J; Kübler W
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):240-6. PubMed ID: 7692164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
    Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
    Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic properties of sotalol and d-sotalol. A current view.
    Touboul P
    Eur Heart J; 1993 Nov; 14 Suppl H():24-9. PubMed ID: 7904935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog.
    Duker G; Almgren O; Carlsson L
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):458-65. PubMed ID: 1279293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological effects of intravenous sotalol in acute myocardial infarction: a double-blind placebo-controlled study.
    Aström M; Edhag O; Nyquist O; Vallin H
    Eur Heart J; 1990 Jan; 11(1):35-42. PubMed ID: 2407533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Popova EP
    Eksp Klin Farmakol; 2003; 66(1):27-33. PubMed ID: 12683077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs.
    Wallace AA; Stupienski RF; Brookes LM; Selnick HG; Claremon DA; Lynch JJ
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):687-95. PubMed ID: 1723765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiological effects of intravenous sotalol. Relation with plasma levels].
    Dumoulin P; Weissenburger J; Poirier JM; Rosensztajn L; Gallet B; Jaillon P; Têtard C; Cheymol G; Valty J
    Arch Mal Coeur Vaiss; 1985 Apr; 78(4):562-8. PubMed ID: 3923983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog.
    Gomoll AW; Lekich RF; Bartek MJ; Comereski CR; Antonaccio MJ
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):204-11. PubMed ID: 1697375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.